CYP1A1 and liver cancer: 2.6. Using the CAFLUX HepG2/DREs-H2B-EGFP Cell Line to Analyze the Effects of Extracellular Vesicles Derived from Adipose-Derived Stem Cells on CYP1A1 Gene Activity in Liver Cancer Cells